NT5E and neoplasm: Inhibiting CD73 enhances T lymphocyte infiltration and tumor cell killing, proposing a strategy to boost antitumor immunity by modulating CD73/adenosine signaling in NK cells, potentially mitigating tumor progression in cancer patients.